Frovatriptan Succinate

CHEMBL2138684 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

379.4 g/mol

LogP

—

Phase

4

This succinate salt form of frovatriptan is an acute migraine treatment that works by stimulating serotonin receptors to reduce the vascular and neurological changes that cause migraine headaches. Its long duration of action may help prevent migraine recurrence within the same day.

Masse moléculaire

379,4000 g/mol

TPSA

147,00 Å²

Aires thérapeutiques

Cardiovascular Disease Migraine Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O.O=C(O)CCC(=O)O

InChI

InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1

Molecular Formula

C18H25N3O6

HBD / HBA

6 / 7

Liaisons Rotatives

5

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This succinate salt form of frovatriptan is an acute migraine treatment that works by stimulating serotonin receptors to reduce the vascular and neurological changes that cause migraine headaches. Its long duration of action may help prevent migraine recurrence within the same day.

Yes, Frovatriptan Succinate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2138684. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 152943. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Frovatriptan Succinate sur PillFYI

Structure

Données Clés

Formule: C18H25N3O6
Synonymes: 2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.